TuHURA Biosciences (HURA) Stock Price, Quote, News & History

Comments

TuHURA Biosciences Inc (HURA) Stock Price, Quote, News & History

HURANASDAQ

Trade with Public

$1.69

0.1912.67%

At close: Mar 9, 5:00 PM EST

$1.68

-0.0119-0.70%

After Hours: 7:57 PM EST

OverviewNews Earnings Analyst Ratings Short Interest Government Trades Stock Report

Key Statistics

Open

$1.53

Close

$1.69

Volume / Avg.

912.58K / 1.60M

Day Range

$1.51 - $1.77

52 Wk Range

0.41 - 4.44

Market Cap

$94.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

16.43%

Days to Cover

1.16

Recent TuHURA Biosciences Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.81M

Investing Cash Flow (TTM)

-7.32M

Financing Cash Flow (TTM)

20.34M

Free Cash Flow (TTM)

-16.88M

Capital Expenditure (TTM)

-69.64K

Net Change in Cash (TTM)

-3.80M

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$83.72M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.19

Earnings Yield % (TTM)

-48.84%

Earnings Yield % (FWD)

-34.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.29

Company Debt

Total Debt

$493.39K

LT Debt

-

LT Debt Issuance (TTM)

$9.50M

LT Debt Repayment (TTM)

-

Total Cash

$2.70M

Debt to Equity

0.04

Issuance of Debt (TTM)

$9.50M

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.53

Close

$1.69

Volume / Avg.

912.58K / 1.60M

Day Range

$1.51 - $1.77

52 Wk Range

0.41 - 4.44

Market Cap

$94.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

16.43%

Days to Cover

1.16

About

Sector

Health Care

Industry

Biotechnology

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy TuHURA Biosciences (HURA) stock?

A

You can purchase shares of TuHURA Biosciences (NASDAQ:HURA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TuHURA Biosciences (HURA) competitors?

A

Other companies in TuHURA Biosciences’s space includes: InflaRx NV (NASDAQ:IFRX), Anixa Biosciences Inc (NASDAQ:ANIX), Fortress Biotech Inc (NASDAQ:FBIO), Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) and Citius Oncology Inc (NASDAQ:CTOR).

Q

What is the forecast, or price target, for TuHURA Biosciences (HURA) stock?

A

TuHURA Biosciences has a consensus price target of $9.67.

Q

What is the current price for TuHURA Biosciences (HURA)?

A

The stock price for TuHURA Biosciences (NASDAQ: HURA) is $1.6781 last updated March 9, 2026 at 7:57 PM EDT.

Q

Does TuHURA Biosciences (HURA) pay a dividend?

A

There are no upcoming dividends for TuHURA Biosciences.

Q

When is TuHURA Biosciences (NASDAQ:HURA) reporting earnings?

A

TuHURA Biosciences does not have any upcoming earnings scheduled.

Q

Is TuHURA Biosciences (HURA) going to split?

A

There is no upcoming split for TuHURA Biosciences.

Q

What sector and industry does TuHURA Biosciences (HURA) operate in?

A

TuHURA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Anixa Biosciences Inc

Coeptis Therapeutics Holdings Inc

PMV Pharmaceuticals Inc

TScan Therapeutics Inc

NASDAQ:TCRX

$1.23

-0.83%

Key Statistics

Open

$1.53

Close

$1.69

Volume / Avg.

912.58K / 1.60M

Day Range

$1.51 - $1.77

52 Wk Range

0.41 - 4.44

Market Cap

$94.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

16.43%

Days to Cover

1.16

Recent TuHURA Biosciences Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.81M

Investing Cash Flow (TTM)

-7.32M

Financing Cash Flow (TTM)

20.34M

Free Cash Flow (TTM)

-16.88M

Capital Expenditure (TTM)

-69.64K

Net Change in Cash (TTM)

-3.80M

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$83.72M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.19

Earnings Yield % (TTM)

-48.84%

Earnings Yield % (FWD)

-34.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.29

Company Debt

Total Debt

$493.39K

LT Debt

-

LT Debt Issuance (TTM)

$9.50M

LT Debt Repayment (TTM)

-

Total Cash

$2.70M

Debt to Equity

0.04

Issuance of Debt (TTM)

$9.50M

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.53

Close

$1.69

Volume / Avg.

912.58K / 1.60M

Day Range

$1.51 - $1.77

52 Wk Range

0.41 - 4.44

Market Cap

$94.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

16.43%

Days to Cover

1.16

About

Sector

Health Care

Industry

Biotechnology

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry